Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-08-17/argenx-soars-on-latest-trial-success-for-autoimmune-drug-vyvgart)